4//SEC Filing
Davarpanah Nicole Negar 4
Accession 0001610618-25-000051
CIK 0001610618other
Filed
May 11, 8:00 PM ET
Accepted
May 12, 8:40 PM ET
Size
7.3 KB
Accession
0001610618-25-000051
Insider Transaction Report
Form 4
Davarpanah Nicole Negar
Chief Medical Officer
Transactions
- Award
Common Stock
2025-05-01+10,000→ 31,692 total - Award
Employee Stock Option (right to buy)
2025-05-01+20,000→ 20,000 totalExercise: $21.75Exp: 2035-04-30→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]Represents time-based Restricted Stock Units (RSUs) granted on May 1, 2025. All RSUs vest in three equal annual installments, with 1/3 vesting on each of June 10, 2026, 2027, and 2028, subject to continuous service through each such Vesting Date.
- [F2]The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of May 1, 2025, subject to continuous service through each such Vesting Date.
Documents
Issuer
Cidara Therapeutics, Inc.
CIK 0001610618
Entity typeother
Related Parties
1- filerCIK 0002067554
Filing Metadata
- Form type
- 4
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 8:40 PM ET
- Size
- 7.3 KB